Cholestasis in Neonates with Red Cell Alloimmune Hemolytic Disease: Incidence, Risk Factors and Outcome

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Neonatology

• Publication date

  2012-02-18

• Fields of study

  Medicine

• Identifiers
  DOI 10.1159/000335333PMID 22354012
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Haematological values in the newborn

  2012cited by this paper
• Intravenous Immunoglobulin in Neonates With Rhesus Hemolytic Disease: A Randomized Controlled Trial

  2011cited by this paper
• Exchange transfusions and top‐up transfusions in neonates with Kell haemolytic disease compared to Rh D haemolytic disease

  2011cited by this paper
• Top‐up transfusions in neonates with Rh hemolytic disease in relation to exchange transfusions

  2010cited by this paper
• Rhesus haemolytic disease of the newborn: Postnatal management, associated morbidity and long-term outcome.

  2008cited by this paper
• Pediatric outcome in Rhesus hemolytic disease treated with and without intrauterine transfusion.

  2008cited by this paper
• A retrospective review of ampicillin-sulbactam and amoxicillin + clavulanate vs cefazolin/cephalexin and erythromycin in the setting of preterm premature rupture of membranes: maternal and neonatal outcomes.

  2007cited by this paper
• A Case of Rhesus Hemolytic Disease With Hemophagocytosis and Severe Iron Overload Due to Multiple Transfusions

  2006cited by this paper
• Roberton's textbook of neonatology

  2005cited by this paper
• Severe conjugated hyperbilirubinaemia and neonatal haemolysis

  2005cited by this paper
• Guideline for the Evaluation of Cholestatic Jaundice in Infants: Recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition

  2004cited by this paper
• Increased Fetal Iron Load in Rhesus Hemolytic Disease

  2004cited by this paper
• Treatment of obstructive jaundice in erythroblastosis fetalis with ursodeoxycholic acid (UDCA): a case report.

  1998cited by this paper
• Neonatal Hepatitis and Excessive Hepatic Iron Deposition Following Intrauterine Blood Transfusion

  1995cited by this paper
• The Effect of Intrauterine Intravascular Blood Transfusion on Iron Metabolism in Fetuses With Rh Alloimmunization

  1991cited by this paper
• Iron overload, free radical damage, and rhesus haemolytic disease.

  1990cited by this paper
• Another cause of neonatal cholestasis.

  1986cited by this paper
• Direct Hyperbilirubinemia Complicating ABO Hemolytic Disease of the Newborn

  1983cited by this paper
• Obstructive Jaundice and Haemolytic Disease of the Newborn

  1963cited by this paper
• Rh Haemolytic Disease of the Newborn, 1960-1961

  1963cited by this paper
• Obstructive jaundice and haemolytic disease of the newborn.

  1959cited by this paper

• Early postnatal management of neonatal RBC alloimmunization.

  2025cites this paper
• The contemporary management of haemolytic disease of the fetus and newborn

  2025cites this paper
• Neutropenia, Thrombocytopenia and Cholestasis in Infants with Rhesus Hemolytic Disease

  2025cites this paper
• Red blood cell alloimmunization and pregnancy: Diagnosis and management

  2025cites this paper
• Hepatic Failure and Hyperbilirubinemia Secondary to Hemolytic Disease of the Newborn

  2024cites this paper
• Incidence and Risk Factors of Cholestasis in Newborns with Hemolytic Disease—A Case-Control Study

  2024cites this paper
• Severe Cholestasis in Neonates with Hemolytic Disease of the Fetus and Newborn—A Case Report

  2024cites this paper
• An ongoing problem: Rhesus hemolytic disease of the newborn - A decade of experience in a single centre.

  2024cites this paper
• Comment on Drozdowska-Szymczak et al. Incidence and Risk Factors of Cholestasis in Newborns with Hemolytic Disease—A Case-Control Study. J. Clin. Med. 2024, 13, 3190

  2024cites this paper
• Heat shock protein HSPA8 impedes hemin-induced cellular-toxicity in liver.

  2024cites this paper
• Management and Treatment Outcomes of Hemolytic Disease of the Fetus and Newborn (HDFN)—A Retrospective Cohort Study

  2024cites this paper
• Hemolytic disease of the fetus and newborn: rapid review of postnatal care and outcomes

  2023cites this paper
• Liver Dysfunction with Severe Cholestasis and Coagulation Disorders in the Course of Hemolytic Disease of the Newborn Requiring Chelation Therapy—A Case Report and Review of the Literature

  2023cites this paper
• A single‐center, retrospective analysis of 17 cases of hemolytic disease of the fetus and newborn caused by anti‐M antibodies

  2023influential citation
• Ursodeoxycholic Acid and SMOFlipid for Treating Parenteral Nutrition Associated Cholestasis in Infants

  2022cites this paper
• History and current standard of postnatal management in hemolytic disease of the fetus and newborn

  2022cites this paper
• Neonatal sepsis in alloimmune hemolytic disease of the fetus and newborn: A retrospective cohort study of 260 neonates

  2022cites this paper
• Population-based incidence and risk factors for cholestasis in hemolytic disease of the fetus and newborn

  2022influential citation
• Management of severe hyperbilirubinemia in the cholestatic neonate: a review and an approach

  2022cites this paper
• A Green-Colored Neonate.

  2021cites this paper
• Conservative Management of Alloimmune Hemolysis and Cholestasis With Extreme Laboratory Abnormalities

  2021cites this paper
• Is There a “Direct” Answer: Should We Perform Exchange Transfusion for Neonatal Predominantly Conjugated Hyperbilirubinemia?

  2021cites this paper
• Identification and management of fetal anaemia: a practical guide

  2021cites this paper
• Rainbow of colors: Inspissated bile syndrome secondary to hemolytic disease of the newborn and concomitant serum dynamics

  2021cites this paper
• Unusual case of immune haemolytic disease causing severe neonatal cholestasis in a newborn

  2021cites this paper
• Prolonged Jaundice in Newborn

  2021cites this paper
• Transient congenital hyperinsulinism and hemolytic disease of a newborn despite rhesus D prophylaxis: a case report

  2021cites this paper
• Hemolysis in Early Infancy: Still a Cause of Cholestatic Neonatal Giant Cell Hepatitis.

  2021cites this paper
• Etiology of neonatal cholestasis after emerging molecular diagnostics

  2021cites this paper
• Immunological Changes In A Fetus With Hemolytic Disease During Rhesus- Immunization Of The Mother

  2020cites this paper
• The rhesus incompatible pregnancy and its consequences for affected fetuses and neonates.

  2020cites this paper
• Medical therapy to attenuate fetal anaemia in severe maternal red cell alloimmunisation

  2020cites this paper
• Red cell alloimmunization: A 2020 update

  2020cites this paper
• Hyporegenerative anemia and other complications of rhesus hemolytic disease: to treat or not to treat is the question

  2019cites this paper
• Severe Fetal Hemolysis and Cholestasis Due to High-Titer Maternal IgG Anti-A Antibodies

  2019cites this paper
• Hyperferritinaemia following intrauterine transfusions for Rh isoimmunisation

  2019cites this paper
• POSTNATAL OUTCOMES OF INFANTS AFFECTED BY RHESUS HEMOLYTIC DISEASE IN A TERTIARY CARE CENTER IN NORTHERN INDIA

  2019cites this paper
• Conservative Management of Hyperferritinemia in Hemolytic Disease of the Fetus and Newborn: A Case Report and Review of the Literature.

  2019cites this paper
• Successful Liver Transplants for Liver Failure Associated With Pyruvate Kinase Deficiency

  2018cites this paper
• Chelation therapy for secondary neonatal iron over load: Lessons learned from rhesus hemolytic disease.

  2018cites this paper
• Neonatal management and outcome in alloimmune hemolytic disease

  2017cites this paper
• Severe case of fetal hemolytic disease caused by anti‐Cw requiring serial intrauterine transfusions complicated by pancytopenia and cholestasis

  2016cites this paper
• Cholestasis and Hepatic Failure in a Neonate: A Case Report of Severe Pyruvate Kinase Deficiency

  2015cites this paper
• Analysis of factors affecting the prognosis of neonatal cholestasis.

  2015cites this paper
• Cholestasis in a neonate with ABO haemolytic disease of newborn following transfusion of ABO group-specific red cells compatible with neonatal serum: inspissated bile syndrome.

  2014cites this paper
• Hydrops fetalis, Anämie und Thrombozytopenie

  2013cites this paper
• Neonatal hemochromatosis: management, outcome, and prevention

  2013cites this paper
• Postnatal outcome in neonates with severe Rhesus c compared to Rhesus D hemolytic disease

  2013cites this paper
• Cholestasis in infants with immune hydrops fetalis.

  2013cites this paper
• Iron status in infants with alloimmune haemolytic disease in the first three months of life

  2013cites this paper